TSX/MBX (TSX/MBX)

Toronto Stock Exchange: TSX/MBX · CAD

CA$0.30

+0.00 (+1.7%)· Recorded snapshot

Market cap	40.4M
Revenue (ttm)	15.4M
Net income (ttm)	-4.9M
EPS (ttm)	-CA$0.04
Shares out	137M
Volume	500
Beta	0.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.4M
Net income (ttm): -4.9M
EPS (ttm): -CA$0.04
Market cap: 40.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-18.2

P25 n/aP50 n/aP75 n/a

ROIC-18

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/MBX indicators

Market & fundamental data

Available fields

196

Groups with data

Currency

CAD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-18
Employees	70
Enterprise value	CAD 40M
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Founded	1988
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA59501P1045
Last earnings date	2026-08-13
Last refreshed	2026-10-29
Market cap	CAD 40.4M
Next earnings date	2026-12-18
Price	CAD 0.30
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	tsx/MBX
Website	https://www.microbix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-12.26%
EV/Sales	2.55x
FCF / EV yield	-9.9%
FCF yield	-9.79%
P/B ratio	1.64x
P/S ratio	2.58x
Price / tangible book value	1.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-27.77%
EBITDA margin	-19.84%
Gross margin	45.9%
Operating margin	-27.77%
Pretax margin	-32.08%
Profit margin	-31.72%
Profit per employee	CAD -48,849
Revenue per employee	CAD 154,002
ROA	-7.39%
ROA (5Y)	3.58%
ROCE	-13.8%
ROE	-18.24%
ROE (5Y)	7.81%
ROIC	-17.96%
ROIC (5Y)	8.87%
SBC / revenue	3.95%
Tax / revenue	-0.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-40.03%
Gross profit growth (Q)	54.7%
Gross profit growth 3Y	-4.35%
Gross profit growth 5Y	-4.16%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-27.13%
Revenue growth (Q)	16.91%
Revenue growth (QoQ)	20.18%
Revenue growth 10Y	6.56%
Revenue growth 3Y	-2.43%
Revenue growth 5Y	-0.35%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -595,172
Depreciation and amortization	CAD 1.2M
EBIT	CAD -4.3M
EBITDA	CAD -3.1M
EPS	CAD -0.04
FCF per share	CAD -0.03
Financing cash flow	CAD -1.1M
Free cash flow	CAD -3.9M
Free cash flow minus SBC	CAD -4.5M
Gross profit	CAD 7.1M
Income taxes	CAD -55,726
Investing cash flow	CAD -595,172
Net borrowing	CAD -275,693
Net cash flow	CAD -4.9M
Net income	CAD -4.9M
Operating cash flow minus SBC	CAD -3.9M
Operating income	CAD -4.3M
Revenue	CAD 15.4M
Stock-based compensation	CAD 607,971

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.22
Book value per share	CAD 0.18
Debt / equity	0.28
Interest coverage	-4.22
Long-term assets	CAD 12.9M
Long-term liabilities	CAD 6.7M
Net cash (debt)	CAD 440,066
Net cash / market cap	1.11%
Net cash growth	-92.27%
Net debt / equity	-0.02
Piotroski F-Score	1
Property, plant and equipment	CAD 9.5M
Shareholders' equity	CAD 24.3M
Tangible book value	CAD 20.9M
Tangible book value per share	CAD 0.15
Total assets	CAD 34.1M
Total cash	CAD 7.2M
Total debt	CAD 6.7M
Total liabilities	CAD 9.8M
WACC	7.92%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	CAD 21.2M
Current liabilities	CAD 3.1M
Current ratio	6.89
Inventory turnover	0.86
Net working capital	CAD 11.2M
Quick ratio	3.17
Working capital	CAD 18.1M
Working capital turnover	0.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.62%
Shareholder yield	1.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	20.83%
10Y return CAGR	1.91%
10Y total return	20.83%
150-day SMA	CAD 0.28
15Y price change	26.09%
15Y return CAGR	1.56%
15Y total return	26.09%
1D price change	1.72%
1M price change	-1.69%
1M total return	-1.69%
1W price change	-9.38%
1W total return	-9.38%
1Y price change	13.73%
1Y return CAGR	13.74%
1Y total return	13.73%
20-day SMA	CAD 0.31
200-day SMA	CAD 0.27
20Y price change	-44.23%
20Y return CAGR	-2.88%
20Y total return	-44.23%
3M price change	-4.92%
3M total return	-4.92%
3Y price change	3.57%
3Y return CAGR	1.18%
3Y total return	3.57%
50-day SMA	CAD 0.30
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 0.33
52-week high date	2026-08-17
52-week low	CAD 0.21
52-week low date	2026-01-21
5Y price change	-58.57%
5Y return CAGR	-16.16%
5Y total return	-58.57%
6M price change	11.54%
6M total return	11.54%
All-time high	CAD 1.90
All-time high date	2000-03-06
All-time low	CAD 0.12
All-time low date	2013-07-24
Average true range (ATR)	CAD 0.01
Average volume	27.4K
Beta (1Y)	0.07
Beta (2Y)	-0.14
Beta (5Y)	0.54
Change from 52-week high	-9.23%
Change from 52-week low	40.48%
Change from all-time high	-84.74%
Change from all-time low	141.67%
Change from open	0%
Day's gap	1.72%
Dollar volume	CAD 148
High price	CAD 0.30
Low price	CAD 0.30
Monthly RSI	48
Open price	CAD 0.30
Previous close	CAD 0.29
Price vs 150-day SMA	2.98%
Price vs 20-day SMA	-5.84%
Price vs 200-day SMA	7.61%
Price vs 50-day SMA	-4.39%
Relative volume	0.02
RSI	39.68
Sharpe ratio	0.43
Sharpe ratio (3Y)	0.14
Sharpe ratio (5Y)	-0.12
Sortino ratio	0.75
Sortino ratio (3Y)	0.34
Sortino ratio (5Y)	-0.06
Volume	500
Weekly RSI	50.15
YTD price change	26.09%
YTD total return	26.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	114M
Shares change (QoQ)	-0.83%
Shares change (YoY)	-1.62%
Shares held by insiders	16.74%
Shares outstanding	137M
Short % of float	0.01%
Short % of shares	0.01%

Deeper analysis on TSX/MBX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/MBX report

Is a complete TSX/MBX research report available?

No complete published report is available for tsx/MBX (TSX/MBX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/MBX (TSX/MBX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/MBX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/MBX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/MBX

Frequently asked questions